title: [Documented advantages of insulin Lantus when compared with NPH insulin].
authors.affiliation: Endokrinologiska kliniken, Universitetssjukhuset MAS, Malmö. anders.frid@skane.se
authors.forename: Anders
authors.initials: A
authors.lastname: Frid
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000069036:Insulin Glargine; D007336:Insulin, Isophane / Q000008:administration & dosage / Q000627:therapeutic use*; D049528:Insulin, Long-Acting; D017410:Practice Guidelines as Topic
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D007336:Insulin, Isophane